Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer

Background Poor prognosis in colon cancer is associated with a high content of cancer-associated fibroblasts (CAFs) and an immunosuppressive tumor microenvironment. The relationship between these two features is incompletely understood. Here, we aimed to generate a model system for studying the interaction between cancer cells and CAFs and their effect on immune-related cytokines and T cell proliferation. Methods CAFs were isolated from colon cancer liver metastases and were immortalized to prolong lifespan and improve robustness and reproducibility. Established medium and matrix compositions that support the growth of patient-derived organoids were adapted to also support CAF growth. Changes in growth pattern and cellular re-organization were assessed by confocal microscopy, live cell imaging, and immunofluorescence. Single cell RNA sequencing was used to study CAF/organoid co-culture-induced phenotypic changes in both cell types. Conditioned media were used to quantify the production of immunosuppressive factors and to assess their effect on T cell proliferation. Results We developed a co-culture system in which colon cancer organoids and CAFs spontaneously organize into superstructures with a high capacity to contract and stiffen the extracellular matrix (ECM). CAF-produced collagen IV provided a basement membrane supporting cancer cell organization into glandular structures, reminiscent of human cancer histology. Single cell RNA sequencing analysis showed that CAFs induced a partial epithelial-to-mesenchymal-transition in a subpopulation of cancer cells, similar to what is observed in the mesenchymal-like consensus molecular subtype 4 (CMS4) colon cancer. CAFs in co-culture were characterized by high expression of ECM components, ECM-remodeling enzymes, glycolysis, hypoxia, and genes involved in immunosuppression. An expression signature derived from CAFs in co-culture identified a subpopulation of glycolytic myofibroblasts specifically residing in CMS1 and CMS4 colon cancer. Medium conditioned by co-cultures contained high levels of the immunosuppressive factors TGFβ1, VEGFA and lactate, and potently inhibited T cell proliferation. Conclusion Co-cultures of organoids and immortalized CAFs recapitulate the histological, biophysical, and immunosuppressive features of aggressive mesenchymal-like human CRC. The model can be used to study the mechanisms of immunosuppression and to test therapeutic strategies targeting the cross-talk between CAFs and cancer cells. It can be further modified to represent distinct colon cancer subtypes and (organ-specific) microenvironments.

[1]  A. Mariotto,et al.  Estimation of the numbers of individuals living with metastatic cancer in the United States. , 2022, Journal of the National Cancer Institute.

[2]  Annelisa M Cornel,et al.  Uncovering the mode of action of engineered T cells in patient cancer organoids , 2022, Nature Biotechnology.

[3]  S. Prabhakar,et al.  Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer , 2022, Nature Genetics.

[4]  P. Gibbs,et al.  Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. , 2022, The Lancet. Oncology.

[5]  S. Terry,et al.  The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? , 2022, Frontiers in Immunology.

[6]  G. Curigliano,et al.  Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers , 2022, Journal for ImmunoTherapy of Cancer.

[7]  Qiang Yu,et al.  Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling , 2021, Cell Death & Disease.

[8]  C. Rudin,et al.  Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. , 2021, Cancer cell.

[9]  P. Sharma,et al.  The Next Decade of Immune Checkpoint Therapy. , 2021, Cancer discovery.

[10]  A. Kundaje,et al.  Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer , 2021, Nature Genetics.

[11]  Heming Ge,et al.  Extracellular Matrix Stiffness: New Areas Affecting Cell Metabolism , 2021, Frontiers in Oncology.

[12]  D. Schrag,et al.  Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. , 2021, JAMA.

[13]  R. Brekken,et al.  Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer , 2021, bioRxiv.

[14]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[15]  Teruhiko Yoshida,et al.  Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs , 2021, Scientific reports.

[16]  P. Gibbs,et al.  Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. , 2020, The New England journal of medicine.

[17]  J. Bluestone,et al.  Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis , 2020, Science Immunology.

[18]  R. Piñeiro,et al.  Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs) , 2020, Cancers.

[19]  J. Galon,et al.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy , 2020, Nature Reviews Cancer.

[20]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[21]  H. Verheul,et al.  Combinatorial Immunotherapies for Metastatic Colorectal Cancer , 2020, Cancers.

[22]  Shannon M. Mumenthaler,et al.  Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance , 2020, Cancers.

[23]  D. Tuveson,et al.  DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS. , 2020, Physiological reviews.

[24]  Y. Cho,et al.  Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer , 2020, Nature Genetics.

[25]  K. Tarte,et al.  Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. , 2020, Cancer discovery.

[26]  E. Puré,et al.  Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy , 2020, Current opinion in immunology.

[27]  Y. Kluger,et al.  Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche , 2020, Nature.

[28]  M. Kreutz,et al.  The immunological Warburg effect: Can a metabolic‐tumor‐stroma score (MeTS) guide cancer immunotherapy? , 2020, Immunological reviews.

[29]  Jun Yu,et al.  Organoid models of gastrointestinal cancers in basic and translational research , 2020, Nature Reviews Gastroenterology & Hepatology.

[30]  Joseph Willson Stress fibres fuel glycolysis , 2020, Nature Reviews Molecular Cell Biology.

[31]  P. Sharma,et al.  Dissecting the mechanisms of immune checkpoint therapy , 2020, Nature Reviews Immunology.

[32]  Marieke E. Ijsselsteijn,et al.  Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4 , 2019, Genome Medicine.

[33]  M. Emberton,et al.  Cancer-associated fibroblasts mediate cancer progression and remodel the tumouroid stroma , 2019, British Journal of Cancer.

[34]  P. Sharma,et al.  Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy , 2019, Cell.

[35]  R. Fodde,et al.  Cell Heterogeneity and Phenotypic Plasticity in Metastasis Formation: The Case of Colon Cancer , 2019, Cancers.

[36]  N. Cho,et al.  Compression-induced expression of glycolysis genes in CAFs correlates with EMT and angiogenesis gene expression in breast cancer , 2019, Communications Biology.

[37]  N. Erez,et al.  The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment , 2019, Front. Immunol..

[38]  Hans Clevers,et al.  Cancer modeling meets human organoid technology , 2019, Science.

[39]  Z. Stadler,et al.  Immunotherapy in colorectal cancer: rationale, challenges and potential , 2019, Nature Reviews Gastroenterology & Hepatology.

[40]  Subha Madhavan,et al.  Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities , 2019, Cell.

[41]  R. Satija,et al.  Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression , 2019, Genome Biology.

[42]  Xinxia Peng,et al.  Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential , 2019, Journal of Cell Science.

[43]  L. Grøntved,et al.  Collagen density regulates the activity of tumor-infiltrating T cells , 2018, Journal of Immunotherapy for Cancer.

[44]  M. Najafi,et al.  Extracellular matrix (ECM) stiffness and degradation as cancer drivers , 2018, Journal of cellular biochemistry.

[45]  E. Batlle,et al.  8 TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis , 2018, ESMO Open.

[46]  F. Marincola,et al.  International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study , 2018, The Lancet.

[47]  H. Clevers,et al.  Organoids in cancer research , 2018, Nature Reviews Cancer.

[48]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[49]  H. Yao,et al.  CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness , 2018, Cell.

[50]  M. Sawyer,et al.  Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  A. van Oudenaarden,et al.  Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations , 2017, Nature Methods.

[52]  U. Martinez-outschoorn,et al.  Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. , 2017, Seminars in oncology.

[53]  C. Punt,et al.  From tumour heterogeneity to advances in precision treatment of colorectal cancer , 2017, Nature Reviews Clinical Oncology.

[54]  Hans Clevers,et al.  Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer , 2017, The Journal of experimental medicine.

[55]  I. Mellman,et al.  Elements of cancer immunity and the cancer–immune set point , 2017, Nature.

[56]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[57]  S. Haferkamp,et al.  LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells. , 2016, Cell metabolism.

[58]  Mauro J. Muraro,et al.  A Single-Cell Transcriptome Atlas of the Human Pancreas , 2016, Cell systems.

[59]  Toshio Uraoka,et al.  A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. , 2016, Cell stem cell.

[60]  Shuqiang Li,et al.  CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq , 2016, Genome Biology.

[61]  Etienne Becht,et al.  Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy , 2016, Clinical Cancer Research.

[62]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[63]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[64]  Hayley E. Francies,et al.  Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.

[65]  G. Inghirami,et al.  Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.

[66]  Camille Stephan-Otto Attolini,et al.  Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.

[67]  Jeffrey R. Whiteaker,et al.  Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.

[68]  A. Oudenaarden,et al.  Validation of noise models for single-cell transcriptomics , 2014, Nature Methods.

[69]  P. Jung,et al.  Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.

[70]  Wayne W. Hancock,et al.  Substrate Rigidity Regulates Human T Cell Activation and Proliferation , 2012, The Journal of Immunology.

[71]  C. Haslinger,et al.  Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. , 2011, The American journal of pathology.

[72]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[73]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[74]  Jiannis Ragoussis,et al.  Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts , 2009, The Journal of Biological Chemistry.

[75]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[76]  P. Friedl,et al.  Mechanoreciprocity in cell migration , 2017, Nature Cell Biology.

[77]  Robert C. Wolpert,et al.  A Review of the , 1985 .